PSA Vice President Professor Mark Naunton MPS[/caption]
Opioid replacement therapy – supporting treatment
Drug dependence, including opioid dependence, involves a complex interplay of social, psychological and biological factors.
Learning objectives
After reading this article, pharmacists should be able...
My Health Record – where to from here?
While the My Health Record (MHR) opt-out date of January 31 has come and gone, people still have the option to permanently delete their...
Bringing pharmacists into the digital future
PSA has unveiled a new digital health report, Connecting the dots: Digitally empowered pharmacists, at the PSA19 conference.
The report, funded by the Australian Digital...
Antioxidants and mineral supplements for slowing age-related macular degeneration
Age-related macular degeneration (AMD) is the most common cause of blindness in developed countries. The prevalence of AMD is 1.4% at 70 years of...
Choosing Wisely: new medicines advice service arrives
The Pharmaceutical Society of Australia (PSA) has released a list of recommendations for healthcare professionals to ensure the safe use of medicines.
The launch of...
PSA’s critical role in 7CPA in spotlight
Federal Health Minister Greg Hunt has asserted the critical role that PSA will play in drafting the 7th Community Pharmacy Agreement (CPA), shaping the...
